Initiative Senegalaise d'Acces aux Antiretroviraux Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2006
NCT00100568
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Initiative Senegalaise d'Acces aux Antiretroviraux (ISAARV)

Active Ingredients

Drugs in Other Trials (3)

efavirenz (sustiva) (1 trial)

lamivudine (epivir) (1 trial)

zidovudine (retrovir) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 3